TIMBER PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana

Kahn Swick & Foti, LLC Investigates Timber Pharmaceuticals, Inc. - TMBR

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Timber Pharmaceuticals, Inc. (“the Company”) (NYSE: TMBR) to LEO Pharma A/S. KSF is seeking to determine whether the transaction and the process that led to it are adequate and fair to the Company’s shareholders.

If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ([e-mail]) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nyse-tmbr/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230829654103/en/

The Timber Pharmaceuticals Stock at the time of publication of the news with a raise of +4,53 % to 3,23USD on NYSE Arca stock exchange (29. August 2023, 17:25 Uhr).